Cargando…
EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
BACKGROUND: This study aims to investigate EGFR as a prognostic biomarker in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: OPSCC patients from retrospective (1998–2009) and prospective cohorts (2014–2017) were included. Retrospectively collected tumors were used to construct tissue microar...
Autores principales: | Sivarajah, Shanmugappiriya, Kostiuk, Morris, Lindsay, Cameron, Puttagunta, Lakshmi, O’Connell, Daniel A., Harris, Jeffrey, Seikaly, Hadi, Biron, Vincent L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327450/ https://www.ncbi.nlm.nih.gov/pubmed/30630536 http://dx.doi.org/10.1186/s40463-018-0323-6 |
Ejemplares similares
-
Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas
por: Lindsay, Cameron D., et al.
Publicado: (2017) -
HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma
por: Xu, Caroline C, et al.
Publicado: (2013) -
Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
por: Idris, Sherif, et al.
Publicado: (2016) -
Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
por: Lindsay, Cameron, et al.
Publicado: (2017) -
Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas
por: Clark, Jessica M., et al.
Publicado: (2018)